Skip to main content

Table 4 Correlations between clinical, metabolic, and cardiovascular parameters and autonomic tests in patients with congenital generalized lipodystrophy and healthy individuals (n = 30)

From: Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in young patients with congenital generalized lipodystrophy

n = 30

LVMI

IVS

cIMT

cQT

SBP drop

 r

0.450

0.545

0.437

0.559

 p

0.012*

0.002*

0.016*

0.001*

30/15

 r

− 0.509

− 0.448

− 0.332

− 0.495

 p

0.004*

0.013*

0.073

0.005*

Valsava

 r

− 0.457

− 0.367

− 0.399

− 0.364

 p

0.011*

0.046*

0.029*

0.048*

E/I

 r

− 0.430

− 0.453

− 0.245

− 0.430

 p

0.016*

0.012*

0.192

0.019*

VLF

 r

− 0.420

− 0.501

− 0.030

− 0.224

 p

0.021*

0.005*

0.873

0.233

LF

 r

− 0.570

− 0.478

− 0.082

− 0.063

 p

0.001*

0.007*

0.666

0.741

HF

 r

− 0.691

− 0.593

− 0.396

− 0.375

 p

0.000*

0.000*

0.030*

0.041*

LF/HF

 r

0.468

0.283

0.465

0.422

 p

0.009*

0.129

0.010*

0.020*

TAS

 r

− 0.650

− 0.415

− 0.180

− 0.286

 p

0.000*

0.023*

0.340

0.125

Leptin

 r

− 0.114

− 0.542

− 0.683

− 0.200

 p

0.550

0.002*

0.000*

0.288

Triglycerides

 r

0.476

0.395

0.548

0.465

 p

0.008*

0.031*

0.002*

0.010*

SBP

 r

0.617

0.594

0.380

0.438

 p

0.000*

0.000*

0.038*

0.015*

DBP

 r

0.531

0.419

0.420

0.467

 p

0.003*

0.021*

0.021*

0.009*

A1c

 r

0.419

0.372

0.460

0.436

 p

0.021*

0.043*

0.011*

0.016*

HOMA-IR

 r

0.789

0.438

0.670

0.676

 p

0.000*

0.016*

0.000*

0.000*

  1. SBP, systolic blood pressure; DBP, diastolic blood pressure; 30/15, 30/15 coefficient; E/I, E/I coefficient; VLF, very low frequency component; LF, low frequency component; HF, high frequency component; TAS, total amplitude spectrum; LVMI, left ventricular mass index; IVS, interventricular septum; cIMT, carotid intimal media thickness; cQT, corrected QT interval; A1c, glycated hemoglobin